GAPDH and non-small cell lung carcinoma: Note, a recent study evidenced Gapdh over-expression to be a prognostic factor for poor outcome in NSCLC patients and was shown to correlate with fluorodeoxyglucose uptake in diagnostic PET imaging [29].